Skip to content
10-Q

Quarterly Report

Edesa Biotech, Inc. EDSA

0001171843-25-003189

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · May 14, 2025 7.02M sh
Cash And Equivalents Q2 2025 · Mar 31, 2025 $13.9M
Current Liabilities Q2 2025 · Mar 31, 2025 $914.7K
Current Liabilities Q2 2025 · Sep 30, 2024 $1.83M
Current Assets Q2 2025 · Mar 31, 2025 $14.39M
Current Assets Q2 2025 · Sep 30, 2024 $1.68M
Total Assets Q2 2025 · Mar 31, 2025 $16.45M
Total Assets Q2 2025 · Sep 30, 2024 $3.81M
Operating Cash Flow Q2 2025 · Mar 31, 2024 −$3.07M
Stockholders Equity Q2 2025 · Mar 31, 2024 $4.32M
Stockholders Equity Q2 2025 · Dec 31, 2023 $5.84M
Stockholders Equity Q2 2025 · Sep 30, 2023 $7.05M
Eps Basic Q2 2025 · Mar 31, 2024 −$0.58
Eps Basic Q2 2025 · Mar 31, 2024 −$1.12
Sga Expense Q2 2025 · Mar 31, 2024 $1.04M
Sga Expense Q2 2025 · Mar 31, 2024 $2.2M
Rd Expense Q2 2025 · Mar 31, 2024 $1.18M
Rd Expense Q2 2025 · Mar 31, 2024 $1.88M
Net Income Q2 2025 · Mar 31, 2024 −$1.86M
Net Income Q2 2025 · Mar 31, 2024 −$3.54M
Operating Income Q2 2025 · Mar 31, 2024 −$2.22M
Operating Income Q2 2025 · Mar 31, 2024 −$4.08M